Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $23.8M
Depreciation & Amortization —
Depreciation —
Amortization —
Stock-Based Compensation $2.6M
Net Cash from Operating Activities $38.7M
Investing Activities
Capital Expenditures $11.0M
Business Acquisitions $1.7M
Net Cash from Investing Activities $-12.5M
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $-5.4M
Net Change in Cash $21.2M
Free Cash Flow $27.7M
← Newer Page 3 of 3 Older →